AOP Orphan is a European pioneer in the development, production and marketing of treatments for people with rare diseases also known as orphan diseases.
"I joined AOP Orphan Ltd in 2016 bringing 25 years experience in senior management within the Healthcare Industry. AOP Orphan has a long history of developing medicines for rare disease and delivering significant improvements to the health of patients! I am committed to introducing that expertise into the UK!"
AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialisation of drugs for more than 20 years already.
Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the UK health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases.
UK occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2012. AOP Orphan UK is a team in the Marketing & Sales for all three therapeutic divisions.